Significant outcomes
-
∙ Variation within the gene GRIN2B may increase risk for alcohol use disorder (AUD).
-
∙ Variation within the gene GRIN2B may be associated with differential brain volume in the left posterior cingulate cortex
Limitations
-
∙ Small sample size.
-
∙ Two different methods were used in the acquisition of brain images.
Introduction
Structural variations in several brain regions have been shown for AUD, in particular, smaller volumes have been found in the prefrontal cortex (Reference Medina, Mcqueeny, Nagel, Hanson, Schweinsburg and Tapert1), right hippocampus (Reference Agartz, Momenan, Rawlings, Kerich and Hommer2,Reference De Bellis, Clark and Beers3), amygdala (Reference Makris, Oscar-Berman, Jaffin, Hodge, Kennedy and Caviness4) and grey and white matter (Reference Gazdzinski, Durazzo, Studholme, Song, Banys and Meyerhoff5,Reference Fein, Greenstein and Cardenas6). In adults with AUD, differential brain volume in the bilateral insular cortex and amygdala was associated with a lack of top–down control over impulsive behaviour (Reference Senatorov, Damadzic and Mann7). Brain structure has considerable heritability (Reference Posthuma, De Geus and Neale8–Reference Thompson, Cannon and Narr10). Genetic variations within serotonin transporter (5-HTT), γ-aminobutyric acid A receptor, α 2 (GABRA2), brain-derived neurotrophic factor (BDNF), catechol-O-methyltransferase, dopamine receptor D2 and corticotropin-releasing hormone receptor 1 have been implicated in the alteration of brain structure and function in adolescents with AUD and alcohol-related phenotypes (Reference Hill, Wang and Kostelnik11–Reference Glaser, Zubieta and Hsu14). Furthermore, in adults with AUD and alcohol-use-related phenotypes, alterations in brain volume are associated with variation in the genes GABRA2, BDNF, glutamate receptor, ionotropic, N-methyl d-aspartate 2B (GRIN2B) and neuregulin 1 (Reference Villafuerte, Heitzeg and Foley15,Reference Vergara, Ulloa, Calhoun, Boutte, Chen and Liu16). Thus, the genes most implicated in AUD to date (in both adults and adolescents) involve neurotransmission.
While previous studies have examined the association between brain volume and genes in adolescents with AUD, these studies either investigated a select number of candidate genes or adopted a volumetric brain region of interest (ROI) approach, which narrowed the scope of the possible exploration. The aim of this investigation was to determine whether a broader range of genetic variants previously implicated across various psychiatric disorders are associated with variation in brain volume specifically in adolescents with AUD.
Material and methods
Participants
Ethical approval for this study was obtained from the Research Ethics Committees of Stellenbosch University (N06/07/128) and the University of Cape Town (HREC REF 023/2012). The cohort consisted of 58 adolescents with AUD and 58 demographically matched (age, gender, language, education level and socio-economic status) healthy control (HC) subjects, with a lifetime dosage not exceeding 76 units of alcohol. Both the AUD and HC groups are of mixed ancestry ethnicity. Eligibility was assessed after a detailed medical history was taken by a fully qualified and licensed psychiatrist. Physical and psychiatric examinations were also undertaken by the psychiatrist and each of the participants underwent urine analysis and breathalyser testing to ensure they were not intoxicated during the testing period. The Schedule for Affective Disorders and Schizophrenia for School Aged Children (6–18 years) Lifetime Version (K-SADS-PL) (Reference Kaufman, Birmaher and Brent17) was administered by a fully qualified and licensed psychiatrist to determine whether any of the participants had current or past psychiatric symptoms (Reference Fein, Greenstein and Cardenas6). In addition, the Timeline Followback procedure was used to determine lifetime history of alcohol use and drinking patterns (Reference Sobell and Sobell18). Childhood adversity was measured by the 28-item Childhood Trauma Questionnaire – Short Form (CTQ-SF) (Reference Bernstein, Stein and Newcomb19).
Exclusion criteria for study participation included diagnoses of mental retardation, lifetime DSM-IV Axis I other than AUD; lifetime dosages exceeding 30 cannabis joints or four methamphetamine doses, current use of sedative or psychotropic medication, signs or history of fetal alcohol syndrome or malnutrition, sensory impairment, history of traumatic brain injury with loss of consciousness exceeding 10 min; presence of diseases that may affect the central nervous system, <6 years of formal education and lack of proficiency in English or Afrikaans. Blood samples were collected for all of the recruited individuals with the appropriate informed consent.
Genotyping
DNA was extracted from the participants’ blood samples using the Maxwell® 16 Blood DNA purification kit (AS1010) (Promega) and the Maxwell 16 instrument (Promega) at the Centre for Proteomic and Genomic Research (Cape Town, South Africa). An Illumina Infinium iSelect custom 6000 bead chip was used to genotype 5348 single nucleotide polymorphisms (SNPs) in 378 candidate genes (genes involved in neurotransmitter and neuroendocrine systems) for post-traumatic stress disorder, and SNPs and copy number variation which were ‘significant hits’ from previous psychiatric GWAS studies. The bead chip was run on the Illumina BeadStation 500 G System at the University of Michigan DNA Sequencing Core (Michigan, Ann Arbor, USA). Case and control samples were analysed together. Genotype calls were made using standard clustering algorithms in the GenomeStudio software (Illumina).
Magnetic resonance imaging (MRI) acquisition
MRIs were collected with a 3 T Siemens Magnetom Allegra MR Headscanner using Syngo MR software (Siemens Medical Solutions). The scanner is located in the Cape Universities Brain Imaging Center at the Stellenbosch University Health Sciences Campus, South Africa. Images for the first 50 subjects (25 HC and 25 AUD) were acquired using a trans-axial T1-weighted acquisition (TR=2080 ms, TE=4.88 mm, acquisition matrix=256×192) at 1.0 mm thickness. The initial review of these images revealed undesirable presence of blood vessels in the imaging, resulting from the scanner being a head-only model that did allow adequate saturation of the blood to suppress signal before the blood flow enters the head. The use of a sagittal T1 protocol was subsequently implemented in place of the original trans-axial acquisition (TR=2200 ms, TE=5.16 ms, acquisition matrix 256×256) at 1.0 mm thickness. The remaining 66 subjects (33 HC and 33 AUD) had an MRI using the sagittal protocol. Of the 50 individuals with a transaxial T1-weighted acquisition, 25 individuals (9 HC and 16 AUD) had an additional MRI with the sagittal protocol. In a previous analysis, we demonstrated that the two acquisition protocols produced comparable images that could be combined for analysis (Reference Fein, Greenstein and Cardenas6).
MRI analysis
After manually reorienting and realigning the cross-hair on the AC-PC plane in all our nifti-converted DICOM T1 images, and initial quality control for signal artefacts, morphological changes were calculated in grey matter by segmenting from white matter and cerebrospinal fluid using the voxel-based morphometry (VBM) unified segmentation approach (Reference Ashburner and Friston20) in SPM8 (www.fil.ucl.acuk/spm8). Following this segmentation procedure, probability maps of grey matter were ‘modulated’ to account for the effect of spatial normalisation, by multiplying the probability value of each voxel by its relative volume in native space before and after warping. Grey matter images, based on probability maps at each voxel, were spatially normalised using a paediatric template from the Cincinnati Children’s Hospital old children template (www.irc.cchmc.org/software/pedbrain.php) and then co-registered using the same segmented template. Modulated images were smoothed with an 8 mm ‘full width half maximum’ Gaussian kernel, in line with other recent VBM studies. This smoothing kernel was applied prior to statistical analysis, to reduce signal noise and to correct for image variability.
Statistical analysis
Exploratory analysis using plink
As an exploratory step, association analysis was conducted using linear regression in Plink (version 1.07) (http://pngu.mgh.harvard.edu/~purcell/plink/). This was to determine whether any of the SNPs (independent variable) had an association with several ROIs (dependent variable) taken from previous publications examining grey matter volume in AUD (Reference Fein, Greenstein and Cardenas6,Reference Vergara, Ulloa, Calhoun, Boutte, Chen and Liu16,Reference Brooks, Dalvie, Cuzen, Cardenas, Fein and Stein21). The ROIs, which were tested separately, were: amygdala, caudate, dorsolateral prefrontal cortex (DLPFC), globus pallidus, hippocampus, insula, occipital lobe, posterior cingulate, precuneus, putamen, superior temporal gyrus and thalamus. The following were included in the regression model as covariates: age, gender, years of education, total matter volume, handedness and protocol. In addition, total CTQ score was added as a covariate as a previous study on this cohort found an association between CTQ score and brain volume (Reference Brooks, Dalvie, Cuzen, Cardenas, Fein and Stein21). All tests were corrected for multiple comparisons (for multiple SNPs) using the Bonferroni correction method.
Voxel-based morphometry
As a follow-up to the initial association findings, the main effects of group (AUD and HC) and of the identified significant SNP genotypes on brain volume data, 2×2 analysis of covariance (ANCOVA) (primary analysis) as well as post-hoc t-tests were implemented using VBM in the SPM8 package (http:www.fil.ucl.ac.uk/spm8). AUD and HC subjects were matched in terms of age, gender and protocol. Because years of education, handedness and protocol were not significantly associated with any brain volume, only age, gender and total matter volume were retained as covariates of no interest to control for global differences in head size. All statistical analyses were corrected for multiple comparisons at the peak voxel level using the family-wise error (FWE), although uncorrected but otherwise significant findings are also reported in the table as an indicator for further more statistically powerful studies to examine.
Results
Participants
See Table 1 for participant details. The median ages of the HC and AUD groups for the total cohort were 14.77 and 14.98, respectively and were not significantly different (Mann–Whitney U-test p=0.159; Table 1). The study participants were predominantly Afrikaans, followed by English speaking and the median number of years of education was 8.0 years for both groups (HC and AUD). The median number of alcohol life dose units for the AUD group in the total cohort was 962.0, and 1.0 for the HC group, where a unit refers to one beer or wine cooler (combination of wine and fruit juice), one glass of wine, or one 43 g shot of liquor (on its own, or in a mixed drink). As expected, adolescents with AUDs had significantly higher lifetime doses of alcohol than the HC group (Mann–Whitney U-test p<0.001; Table 1). The median total CTQ score was 36.0 and 42.0 for the HC and AUD group, respectively.
Table 1 Median values and interquartile range for cohort characteristics
AUD, alcohol use disorder; CTQ, Childhood Trauma Questionnaire.
* Pearson χ2 test (df=1).
† Alcohol life dose was measured in units. One unit was defined as one beer or wine cooler (combination of wine and fruit juice), one glass of wine, or one 43 g shot of liquor (alone or in a mixed drink).
Statistical analysis
Exploratory analysis using plink
All samples had a call rate of >99%. Before genotyping and frequency pruning there were 4656 SNPs. A total of nine SNPs failed the missingness test (i.e. only SNPs with a genotyping rate of 90% were included) and 600 SNPs were excluded because of a minor allele frequency of <0.05. A total of 4 SNPs were excluded as these were out of Hardy–Weinberg equilibrium (p<0.00001). From the exploratory analysis, only one SNP, rs219927 located in an intron of the gene GRIN2B was associated with ROI brain volume in the left posterior cingulate cortex (corrected p<0.05), whereby having a G-allele was associated with a bigger volume. From this, four ‘functional’ variants [two exonic (rs1806201 and rs7301328) and two located in the 3′ untranslated region (UTR) (rs890 and rs1805502)] within the GRIN2B gene were investigated to determine whether these variants were associated with variation in brain volume that was not detected in the earlier association tests due to the multiple testing burden. It was found that the 3′ UTR SNP, rs890, was associated with brain volume in the left and right DLPFC (corrected p<0.05), whereby an A-allele was associated with a bigger volume.
Voxel-based morphometry
In order to validate the findings from the initial association analyses, ANCOVA (primary analysis) and post-hoc t-tests for brain volume and genotype (rs219927 and rs890 in GRIN2B in two separate ANCOVA analyses) were conducted using VBM. For rs890, a main effect (primary analysis) of group was found for the right inferior temporal gyrus (Table 2); however no significant (FWE corrected) main effects for genotype or interactions were obtained (see Table S2 for uncorrected findings). No significant (FWE corrected) associations were found for rs219927 (see Table S1 for uncorrected findings). The uncorrected findings for rs890 and rs219927 are described below.
Table 2 2×2 analysis of covariance (ANCOVA) with SNP rs890 (group×genotype) and matched for age, gender, group and protocol (with total matter volume, age, gender and total CTQ as covariates of no interest)
CTQ, Childhood Trauma Questionnaire; FEW, family wise error corrected for multiple comparison (at the peak voxel level); MNI, Montreal Neurological Institute Coordinates.
The ANCOVAs (primary analysis) showed a main effect for rs219927 in the left orbitofrontal cortex (OFC) (x=−21, y=37, z=−16, uncorrected p<0.05) (Table S1). Post-hoc tests indicated that volume in the left OFC was smaller in individuals with the AA genotype compared with those homozygous for the G-allele (uncorrected p<0.001) (Table S1). For rs890, a main effect of genotype (primary analysis) was observed in the left parahippocampal gyrus (x=−24, y=−30, z=−21, uncorrected p<0.001) and the left OFC (x=−24, y=24, z=−19, uncorrected p<0.001) (Table S2). In addition, a genotype by group interaction (primary analysis) was detected for the left OFC (x=−24, y=24, z=−19, uncorrected p<0.001). From the post-hoc analysis it was seen that individuals with AUD and the AA genotype had smaller volumes in the left OFC (x=−34, y=32, z=5, uncorrected p<0.001) (Figure S1) (Table S2).
Discussion
This study is the first to explore which genes, from a large sample of SNPs commonly associated with psychiatric disorders, are associated with brain volume differences in adolescents with AUD versus healthy controls. It was found that an intronic SNP rs219927 within the gene GRIN2B, is associated with larger left posterior cingulate cortex volume in AUD.
The initial exploratory analysis showed that the GRIN2B SNP rs219927 may be associated with larger volume in the left posterior cingulate. GRIN2B (12p12) encodes the 2B subunit of the ionotropic N-methyl-d-aspartate (NMDA) glutamate receptor (Reference Collingridge, Olsen, Peters and Spedding22) and in brain tissue is primarily expressed in the fronto-parieto-temporal cortex and the hippocampal pyramidal cells (Reference Schito, Pizzuti and Di Maria23). The NMDA receptor is an ion-gated channel which plays a role in the process of long-term potentiation and is thought to be involved in learning and memory (Reference Ishii, Moriyoshi and Sugihara24). Genetic polymorphisms within GRIN2B have previously been associated with variation in brain structure. In particular, the GRIN2B SNP rs890 was shown to have an association with reduced fractional anisotropy in several brain areas, including the bilateral frontal region and left cingulate gyrus, in individuals with bipolar disorder (Reference Kuswanto, Sum and Thng25). Our findings support previous research implicating the GRIN2B gene in AUD, and linking it to the posterior cingulate, although in adults the volume is smaller not larger (Reference Vergara, Ulloa, Calhoun, Boutte, Chen and Liu16). Speculatively, it may be that a relationship exists between age, alcohol exposure and brain volume in the posterior cingulate cortex. In other words, children and adolescents’ behaviour are influenced strongly by reward processes, whereas as we age and the prefrontal cortex develops, there is a greater attempt by executive functions to modulate reward and impulsive responses to stimuli such as alcohol. Increased posterior cingulate cortex activation positively correlates with a loss of behavioural control over alcohol in response to craving cues in individuals exposed to alcohol (Reference Liu, Claus, Calhoun and Hutchison26). While it is still not entirely clear as to how the posterior cingulate cortex contributes to AUD in adolescents; the volume of this region appears to differ in relation to variation in GRIN2B.
In the current investigation, uncorrected findings showed that the GRIN2B SNPs rs219927 and SNP rs890 may be associated with smaller volume in the OFC, a brain region involved in the process of decision making (Reference Bechara, Damasio and Damasio27) and reward-related behaviour in response to taste, smell and visual cues (Reference Rolls28,Reference Kringelbach29). The OFC is implicated in a cortico-striatal-limbic neural circuit accounting for alcohol craving and relapse following a period of abstinence, incorporating the medial prefrontal cortex, anterior cingulate cortex, striatum and amygdala (Reference Seo and Sinha30). Damage to, or deficits in this circuitry therefore, may contribute to impairments in executive functioning, emotion regulation and decision making observed in those with AUD.
This study has some strengths and limitations that must be considered when interpreting our findings. For a gene-imaging study our cohort (AUD=58, HC=58) is relatively small, and future brain imaging studies would benefit from increasing the sample. While, we conducted a powerful and rigorous pre-analysis of the SNPs most associated with previously defined brain volumes of interest implicated in AUD, we cannot rule out false negative findings. Also, the regions identified from the initial exploratory analysis were not found in the ANCOVA analysis, possibly due to a lack of power. In addition, our brain imaging method might have been flawed by the trans-axial to sagittal acquisition differences, although our preliminary analyses of potential artefacts between these two approaches revealed no significant effect.
In conclusion, the GRIN2B gene, involved in glutamatergic signalling, may be associated with developmental differences in brain regions such as the posterior cingulate cortex. Such differences may play a role in risk for AUD. These findings deserve further detailed investigation in larger cohorts.
Acknowledgements
This work was supported by an NIAAA grant (AA016303), and the Claude Leon Foundation Fellowship (SJB). The authors acknowledge the support of the National Research Foundation (NRF), the Medical Research Council of South Africa and the University of Cape Town (UCT).
Authors Contributions: SD co-ordinated the molecular genetic work, performed the statistical analysis and helped to draft the manuscript. SJB performed the brain imaging and statistical analysis, and helped to draft the manuscript. VC participated in the study design and coordination and helped to draft the manuscript. GF conceived of the study and participated in its design and coordination. RR conceived of the study and participated in its design and coordination. DJS conceived of the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Financial Support
This work was supported by a National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant (AA016303), and the Claude Leon Foundation Fellowship. The authors acknowledge the support of the National Research Foundation (NRF), the Medical Research Council of South Africa and the University of Cape Town (UCT).
Conflicts of Interest
The authors declare that they have no competing interest.
Ethical Standards
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
Supplementary material
To view supplementary material for this article, please visit http://dx.doi.org/10.1017/neu.2016.41
